The cancer-predicting blood test Grail got a lot of hype several years ago. Now, there's concern that maybe it's not as good as initially thought.
––– 凄い –––
Oh-oh.Grail is facing a class action lawsuit in the US. Embittered investors, faced with steep losses, claim the company exaggerated Galleri's effectiveness in order to increase share price.
Sugar-substitute erythritol may enhance platelet aggregation, leading to strokes. All the sugar substitutes are flawed. Except maybe monkfruit sweetener, which actually tastes pretty close to sugar. That's the only one I'll use.
––– 凄い –––
A substance, compound DDL-920, was shown (in mice) to "restore cognition, memory in Alzheimer’s disease". Sounds promising, but many a drug has failed phase III clinical trials. Don't get too excited yet.
––– 凄い –––
Sounds like Gilligan's Island. These two were supposed to be in space for only 8 days. Now they can't return until 2025, earliest. Jeez.
––– 凄い –––
Nice review of Universal Basic Income, and why it fails. The people that need to read it, probably won't.
––– 凄い –––
The first nasal-spray delivery anaphylaxis treatment drug was FDA-approved. It's called Neffy.
––– 凄い –––